Ochre Bio is a biotechnology company developing RNA therapies for chronic liver diseases. Using a combination of genomic deep phenotyping, precision RNA medicine, and testing in live human donor livers, Ochre is developing therapies for important liver health challenges, from increasing donor liver supply to reducing cirrhosis complications. To learn more, please visit www.ochre-bio.com.
View Top Employees from Ochre BioWebsite | https://www.ochre-bio.com/ |
Employees | 55 (55 on RocketReach) |
Founded | 2019 |
Technologies |
HTML,
PHP,
Nginx
+5 more
(view full list)
|
Industry | Biotechnology Research, Biotechnology, Pharmaceuticals |
Looking for a particular Ochre Bio employee's phone or email?
Quin Wills is the Chief Strategy Officer, Co-Founder of Ochre Bio.
55 people are employed at Ochre Bio.
Ochre Bio is based in Oxford, England.